Metabolism of kidney cancer

From the lab to clinical practice

Sunil Sudarshan, Jose A. Karam, James Brugarolas, R. Houston Thompson, Robert Uzzo, Brian Rini, Vitaly Margulis, Jean Jacques Patard, Bernard Escudier, W. Marston Linehan

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Context: There is increasing evidence for the role of altered metabolism in the pathogenesis of renal cancer. Objective: This review characterizes the metabolic effects of genes and signaling pathways commonly implicated in renal cancer. Evidence acquisition: A systematic review of the literature was performed using PubMed. The search strategy included the following terms: renal cancer, metabolism, HIF, VHL. Evidence synthesis: Significant progress has been made in the understanding of the metabolic derangements present in renal cancer. These findings have been derived through translational, in vitro, and in vivo studies. To date, the most well-characterized metabolic features of renal cancer are linked to von Hippel-Lindau (VHL) loss. VHL loss and the ensuing increase in the expression of hypoxia-inducible factor affect several metabolic pathways, including glycolysis and oxidative phosphorylation. Collectively, these changes promote a glycolytic metabolic phenotype in renal cancer. In addition, other histologic subtypes of renal cancer are also notable for metabolic derangements that are directly related to the causative genes. Conclusions: Current knowledge of the genetics of renal cancer has led to significant understanding of the metabolism of this malignancy. Further studies of the metabolic basis of renal cell carcinoma should provide the foundation for the development of new treatment approaches and development of novel biomarkers.

Original languageEnglish (US)
Pages (from-to)244-251
Number of pages8
JournalEuropean Urology
Volume63
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Kidney Neoplasms
Oxidative Phosphorylation
Glycolysis
Metabolic Networks and Pathways
Renal Cell Carcinoma
PubMed
Genes
Biomarkers
Phenotype

Keywords

  • Kidney cancer
  • Metabolism

ASJC Scopus subject areas

  • Urology

Cite this

Sudarshan, S., Karam, J. A., Brugarolas, J., Thompson, R. H., Uzzo, R., Rini, B., ... Linehan, W. M. (2013). Metabolism of kidney cancer: From the lab to clinical practice. European Urology, 63(2), 244-251. https://doi.org/10.1016/j.eururo.2012.09.054

Metabolism of kidney cancer : From the lab to clinical practice. / Sudarshan, Sunil; Karam, Jose A.; Brugarolas, James; Thompson, R. Houston; Uzzo, Robert; Rini, Brian; Margulis, Vitaly; Patard, Jean Jacques; Escudier, Bernard; Linehan, W. Marston.

In: European Urology, Vol. 63, No. 2, 02.2013, p. 244-251.

Research output: Contribution to journalArticle

Sudarshan, S, Karam, JA, Brugarolas, J, Thompson, RH, Uzzo, R, Rini, B, Margulis, V, Patard, JJ, Escudier, B & Linehan, WM 2013, 'Metabolism of kidney cancer: From the lab to clinical practice', European Urology, vol. 63, no. 2, pp. 244-251. https://doi.org/10.1016/j.eururo.2012.09.054
Sudarshan, Sunil ; Karam, Jose A. ; Brugarolas, James ; Thompson, R. Houston ; Uzzo, Robert ; Rini, Brian ; Margulis, Vitaly ; Patard, Jean Jacques ; Escudier, Bernard ; Linehan, W. Marston. / Metabolism of kidney cancer : From the lab to clinical practice. In: European Urology. 2013 ; Vol. 63, No. 2. pp. 244-251.
@article{d067bbfc865d4756853a430ab3b7f7a1,
title = "Metabolism of kidney cancer: From the lab to clinical practice",
abstract = "Context: There is increasing evidence for the role of altered metabolism in the pathogenesis of renal cancer. Objective: This review characterizes the metabolic effects of genes and signaling pathways commonly implicated in renal cancer. Evidence acquisition: A systematic review of the literature was performed using PubMed. The search strategy included the following terms: renal cancer, metabolism, HIF, VHL. Evidence synthesis: Significant progress has been made in the understanding of the metabolic derangements present in renal cancer. These findings have been derived through translational, in vitro, and in vivo studies. To date, the most well-characterized metabolic features of renal cancer are linked to von Hippel-Lindau (VHL) loss. VHL loss and the ensuing increase in the expression of hypoxia-inducible factor affect several metabolic pathways, including glycolysis and oxidative phosphorylation. Collectively, these changes promote a glycolytic metabolic phenotype in renal cancer. In addition, other histologic subtypes of renal cancer are also notable for metabolic derangements that are directly related to the causative genes. Conclusions: Current knowledge of the genetics of renal cancer has led to significant understanding of the metabolism of this malignancy. Further studies of the metabolic basis of renal cell carcinoma should provide the foundation for the development of new treatment approaches and development of novel biomarkers.",
keywords = "Kidney cancer, Metabolism",
author = "Sunil Sudarshan and Karam, {Jose A.} and James Brugarolas and Thompson, {R. Houston} and Robert Uzzo and Brian Rini and Vitaly Margulis and Patard, {Jean Jacques} and Bernard Escudier and Linehan, {W. Marston}",
year = "2013",
month = "2",
doi = "10.1016/j.eururo.2012.09.054",
language = "English (US)",
volume = "63",
pages = "244--251",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Metabolism of kidney cancer

T2 - From the lab to clinical practice

AU - Sudarshan, Sunil

AU - Karam, Jose A.

AU - Brugarolas, James

AU - Thompson, R. Houston

AU - Uzzo, Robert

AU - Rini, Brian

AU - Margulis, Vitaly

AU - Patard, Jean Jacques

AU - Escudier, Bernard

AU - Linehan, W. Marston

PY - 2013/2

Y1 - 2013/2

N2 - Context: There is increasing evidence for the role of altered metabolism in the pathogenesis of renal cancer. Objective: This review characterizes the metabolic effects of genes and signaling pathways commonly implicated in renal cancer. Evidence acquisition: A systematic review of the literature was performed using PubMed. The search strategy included the following terms: renal cancer, metabolism, HIF, VHL. Evidence synthesis: Significant progress has been made in the understanding of the metabolic derangements present in renal cancer. These findings have been derived through translational, in vitro, and in vivo studies. To date, the most well-characterized metabolic features of renal cancer are linked to von Hippel-Lindau (VHL) loss. VHL loss and the ensuing increase in the expression of hypoxia-inducible factor affect several metabolic pathways, including glycolysis and oxidative phosphorylation. Collectively, these changes promote a glycolytic metabolic phenotype in renal cancer. In addition, other histologic subtypes of renal cancer are also notable for metabolic derangements that are directly related to the causative genes. Conclusions: Current knowledge of the genetics of renal cancer has led to significant understanding of the metabolism of this malignancy. Further studies of the metabolic basis of renal cell carcinoma should provide the foundation for the development of new treatment approaches and development of novel biomarkers.

AB - Context: There is increasing evidence for the role of altered metabolism in the pathogenesis of renal cancer. Objective: This review characterizes the metabolic effects of genes and signaling pathways commonly implicated in renal cancer. Evidence acquisition: A systematic review of the literature was performed using PubMed. The search strategy included the following terms: renal cancer, metabolism, HIF, VHL. Evidence synthesis: Significant progress has been made in the understanding of the metabolic derangements present in renal cancer. These findings have been derived through translational, in vitro, and in vivo studies. To date, the most well-characterized metabolic features of renal cancer are linked to von Hippel-Lindau (VHL) loss. VHL loss and the ensuing increase in the expression of hypoxia-inducible factor affect several metabolic pathways, including glycolysis and oxidative phosphorylation. Collectively, these changes promote a glycolytic metabolic phenotype in renal cancer. In addition, other histologic subtypes of renal cancer are also notable for metabolic derangements that are directly related to the causative genes. Conclusions: Current knowledge of the genetics of renal cancer has led to significant understanding of the metabolism of this malignancy. Further studies of the metabolic basis of renal cell carcinoma should provide the foundation for the development of new treatment approaches and development of novel biomarkers.

KW - Kidney cancer

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=84871923896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871923896&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.09.054

DO - 10.1016/j.eururo.2012.09.054

M3 - Article

VL - 63

SP - 244

EP - 251

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -